
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Indian market indicators point to a strong opening as a US-Iran ceasefire agreement causes a sharp plunge in global crude oil prices, boosting investor sentiment.
Indian stock markets face a potential 10% correction as surging crude oil prices above $100 per barrel threaten economic stability and corporate earnings amid geopolitical tensions.
Prestige Estates Projects reports a 39% year-on-year increase in Q3 FY26 sales bookings to ₹4,184 crore, driven by strong housing demand across major Indian cities.
Ola Group, led by Ola Electric, holds over half of all patents granted to India's 117 unicorns, highlighting a significant focus on deep-tech innovation.
Foreign portfolio investors withdrew a record Rs 1.14 lakh crore from Indian equities in March 2026, driven by geopolitical tensions and macroeconomic concerns.
Biocon has commercially launched its denosumab biosimilars, Bosaya™ and Aukelso™, in the United States, aiming to provide affordable treatment for osteoporosis and cancer-related bone conditions.
SEBI extends the validity of IPO approvals to September 30, 2026, offering relief to companies facing fundraising challenges amid geopolitical tensions and weak market sentiment.
Global markets experience a significant relief rally, with oil prices falling sharply and stocks surging after the US announced a two-week ceasefire with Iran.
NATO Secretary-General Mark Rutte will meet US President Donald Trump in Washington to address rising tensions over the Iran war and the future of the alliance.
Gautam Adani and his nephew have asked a US court to dismiss a securities fraud lawsuit, arguing the case is outside US jurisdiction and lacks evidence.
An in-depth analysis comparing Elevance Health (ELV) and Centene (CNC) on financial health, valuation, and strategic direction to determine the better investment for 2026.
The Reserve Bank of India's Monetary Policy Committee is expected to hold the repo rate at 5.25% in its April 2026 review amid rising crude oil prices and geopolitical tensions.
Nearly two-thirds of Indian IPOs listed in the past year are trading below their issue price, signaling a sharp shift in investor sentiment amid market volatility.
Pfizer Ltd's shares in India face selling pressure as its US parent grapples with declining COVID-19 revenues, muted 2026 guidance, and significant policy risks.
Health insurance stocks like UnitedHealth, Humana, and CVS surged after the Trump administration announced a higher-than-expected 2.48% Medicare Advantage payment increase for 2027.
Titan Company reports a 22% revenue growth for FY25, crossing the ₹50,000 crore milestone, driven by strong performance in its jewellery and watches divisions.